A Novel Plasma Heme Assay Reveals Disease Severity in Beta‐Thalassemia and Sickle Cell Anemia
American Journal of Hematology · 2026-07 · 101 (7) · 1706-1716
DOI: 10.1002/ajh.70314 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hematology, online erschienen am 22.04.2026. Verfasst von Laurent Kiger und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institut Mondor de Recherche Biomédicale, Créteil, France. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, beta-Thalassemia, Heme. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Anemia results from imbalanced hemoglobin or red blood cell production and clearance. Hemolytic anemia, caused by premature red blood cell removal, can be intravascular (in blood) or extravascular (erythrophagocytosis). Hemolysis is common in Sickle Cell Disease (SCD) and Beta‐Thalassemia anemia (β‐thalassemia), the most prevalent inherited hemolytic anemias. Hemolysis severity is primarily assessed by measuring indirect serum biomarkers such as lactate dehydrogenase, released by cytolysis, bilirubin and haptoglobin. However, these markers do not directly indicate either the cause or the primary site of hemolysis. We introduced a novel plasma heme assay that quantifies all heme‐related species in plasma, including hemoglobin, methemoglobin, heme, and hemopexin. Our findings revealed a more profound intravascular red blood cell destruction in SCD compared to β‐thalassemia as demonstrated by higher values of plasma hemoglobin, respectively 6.20 and 2.52 μM ( p < 0.001), with significant inter‐individual variability. In contrast, β‐thalassemia patients exhibited higher plasma heme values (11.00 μM vs. 1.51 μM; p < 0.0001) reflecting a probable mixed origin (dyserythropoiesis and hemolysis). Plasma hemopexin was negatively correlated with plasma heme in all patients. Plasma heme exceeded hemopexin scavenging capability in 72% of β‐thalassemia and 36% of SCD patients. In β‐thalassemia, plasma heme levels were significantly higher in transfusion‐dependent compared to non–transfusion‐dependent patients, indicating that excess heme reflects clinical severity. In SCD, elevated concentration of excess heme was associated with a significant increased risk of mortality compared to LDH or reticulocytes%. This novel spectral assay offered significant benefits for diagnosis, treatment, and patient management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut Mondor de Recherche Biomédicale, Créteil, France.
- Sickle Cell Referral Center, UMGGR, Plateforme D'expertise Maladies Rares Grand Paris Est, UPEC Hôpitaux Universitaires Henri Mondor, APHP, Créteil, France.
- Etablissement Français du Sang, Créteil, France.
- INNOVHEM, Créteil, France.
- Réseau Erythrocyte Drépanocytose, RED, Créteil, France.
- Département de Biochimie et Pharmacology, UPEC Hôpitaux Universitaires Henri Mondor, APHP, Créteil, France.
ORCID-Profile: Nicolas Hebert
Zitieren
APA
Kiger, L., Hebert, N., Bencheikh, L., de Pierrefeu, V. M. D., d'Alexandry d'Orengiani, A. P. H., Adypagavane, S., Perkins, M., Matabishi-Bibi, L., Pirenne, F., Berquet, C., Moutereau, S., Pissard, S., Galactéros, F., Marden, M. C., & Bartolucci, P. (2026). A Novel Plasma Heme Assay Reveals Disease Severity in Beta‐Thalassemia and Sickle Cell Anemia. American Journal of Hematology, 101(7), 1706-1716. https://doi.org/10.1002/ajh.70314
Vancouver
Kiger L, Hebert N, Bencheikh L, de Pierrefeu VMD, d'Alexandry d'Orengiani APH, Adypagavane S, et al. A Novel Plasma Heme Assay Reveals Disease Severity in Beta‐Thalassemia and Sickle Cell Anemia. American Journal of Hematology. 2026;101(7):1706-1716. doi:10.1002/ajh.70314
BibTeX
@article{Kiger2026,
author = {Kiger, Laurent and Hebert, Nicolas and Bencheikh, Laura and de Pierrefeu, Vincent Malcor Deydier and d'Alexandry d'Orengiani, Anne-Laure Pham Hung and Adypagavane, Sandia and Perkins, Meghan and Matabishi-Bibi, Laura and Pirenne, France and Berquet, Claire and Moutereau, Stephane and Pissard, Serge and Galactéros, Frédéric and Marden, Michael C and Bartolucci, Pablo},
title = {A Novel Plasma Heme Assay Reveals Disease Severity in Beta‐Thalassemia and Sickle Cell Anemia},
journal = {American Journal of Hematology},
year = {2026},
volume = {101},
number = {7},
pages = {1706--1716},
doi = {10.1002/ajh.70314}
}
EUVIMED